Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery (Q45886136)

17 December 2017

title

Multigene/multisubtype HIV-1 vaccine induces potent cellular and humoral immune responses by needle-free intradermal delivery (English)

1 reference

17 December 2017

author

Karl Ljungberg

2

1 reference

17 December 2017

Jorma Hinkula

8

1 reference

17 December 2017

Britta Wahren

9

object named as

Britta Wahren

1 reference

17 December 2017

author name string

Andreas Bråve

1

1 reference

17 December 2017

Andreas Boberg

3

1 reference

17 December 2017

Erik Rollman

4

1 reference

17 December 2017

Maria Isaguliants

5

1 reference

17 December 2017

Björn Lundgren

6

1 reference

17 December 2017

Pontus Blomberg

7

1 reference

17 December 2017

publication date

22 August 2005

1 reference

17 December 2017

published in

Molecular Therapy

1 reference

17 December 2017

volume

12

1 reference

17 December 2017

issue

6

1 reference

17 December 2017

page(s)

1197-1205

1 reference

17 December 2017

cites work

HIV vaccine strategies

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Prospects for vaccine protection against HIV-1 infection and AIDS.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

DNA vaccines against human immunodeficiency virus type 1 in the past decade

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Genetic subtypes, humoral immunity, and human immunodeficiency virus type 1 vaccine development

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

HIV subtypes and recombination strains--strategies for induction of immune responses in man.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Multi-subtype gp160 DNA immunization induces broadly neutralizing anti-HIV antibodies.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

7 January 2021

DNA vaccines: a review

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Gene gun-based nucleic acid immunization: elicitation of humoral and cytotoxic T lymphocyte responses following epidermal delivery of nanogram quantities of DNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Topical delivery of imiquimod to a mouse model as a novel adjuvant for human immunodeficiency virus (HIV) DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Predominant role for directly transfected dendritic cells in antigen presentation to CD8+ T cells after gene gun immunization.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Needle-free Biojector injection of a dengue virus type 1 DNA vaccine with human immunostimulatory sequences and the GM-CSF gene increases immunogenicity and protection from virus challenge in Aotus monkeys

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Hepatitis A vaccine administration: comparison between jet-injector and needle injection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Critical role for Env as well as Gag-Pol in control of a simian-human immunodeficiency virus 89.6P challenge by a DNA prime/recombinant modified vaccinia virus Ankara vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Control of a mucosal challenge and prevention of AIDS by a multiprotein DNA/MVA vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Gene inoculation generates immune responses against human immunodeficiency virus type 1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Imiquimod and resiquimod in a mouse model: adjuvants for DNA vaccination by particle-mediated immunotherapeutic delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Effect on antibody and T-cell responses of mixing five GMP-produced DNA plasmids and administration with plasmid expressing GM-CSF.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

A DNA vaccine encoding the 42 kDa C-terminus of merozoite surface protein 1 of Plasmodium falciparum induces antibody, interferon-gamma and cytotoxic T cell responses in rhesus monkeys: immuno-stimulatory effects of granulocyte macrophage-colony sti

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Boosting of DNA vaccine-elicited gamma interferon responses in humans by exposure to malaria parasites

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Evaluation of tolerability and antibody response after recombinant human granulocyte-macrophage colony-stimulating factor (rhGM-CSF) and a single dose of recombinant hepatitis B vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Durable carcinoembryonic antigen (CEA)-specific humoral and cellular immune responses in colorectal carcinoma patients vaccinated with recombinant CEA and granulocyte/macrophage colony-stimulating factor.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Pharmacological administration of granulocyte/macrophage-colony-stimulating factor is of significant importance for the induction of a strong humoral and cellular response in patients immunized with recombinant carcinoembryonic antigen

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

DNA vaccines: progress and challenges

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

rev protein of human immunodeficiency virus type 1 affects the stability and transport of the viral mRNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

A second post-transcriptional trans-activator gene required for HTLV-III replication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

HIV-specific cellular immune response is inversely correlated with disease progression as defined by decline of CD4+ T cells in relation to HIV RNA load

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Quantitation of HIV-1-Specific Cytotoxic T Lymphocytes and Plasma Load of Viral RNA

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

DNA-encoding enzymatically active HIV-1 reverse transcriptase, but not the inactive mutant, confers resistance to experimental HIV-1 challenge.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Enhanced immune responses after DNA vaccination with combined envelope genes from different HIV-1 subtypes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Interactions of single and combined human immunodeficiency virus type 1 (HIV-1) DNA vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

The timing of GM-CSF expression plasmid administration influences the Th1/Th2 response induced by an HIV-1-specific DNA vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Mucosal and plasma IgA from HIV-exposed seronegative individuals neutralize a primary HIV-1 isolate

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Functional HIV-1 specific IgA antibodies in HIV-1 exposed, persistently IgG seronegative female sex workers

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Progress toward an HIV vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Production of neutralizing granulocyte-macrophage colony-stimulating factor (GM-CSF) antibodies in carcinoma patients following GM-CSF combination therapy.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Plasmid DNA malaria vaccine: tissue distribution and safety studies in mice and rabbits

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

Epitope mapping of the HIV-1 gag region with monoclonal antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.YMTHE.2005.06.473

10.1016/J.YMTHE.2005.06.473

7 January 2021

Identifiers

DOI

1 reference

17 December 2017

1 reference

17 December 2017